BRIEF-Zynerba Pharmaceuticals announces positive top line results from ZYN002 cbd gel phase 1 multiple rising dose trial
June 27, 2016 at 16:16 PM EDT
* Announces positive top line results from ZYN002 cbd gel phase 1 multiple rising dose trial and initiation of phase 2 study in adult epilepsy patients with refractory focal seizures
